Kieliszek, A. M., Apel, E., Zheng, S., Piotrowski, M., Chui, D., Alazet, S., Shamsi, S., Mobilio, D., Johnson, J. W., Escudero, L., Vandevoorde, K., Mei, L., Acevedo, M., Sabbatani, J., Kent, O. A., Dordahan, F., Yadav, A., MacKay, B., Leguay, K., Berger, K. J., Miletic, P., Zhai, K., Ang, P., Huebner, A., Chafe, S. C., Sturino, C., Szychowski, J., Venugopal, C., Mancini, J., Phinney, A. L., Magolan, J., Singh, S. K. (2026). Selectively targeting inosine monophosphate dehydrogenase-2 impairs brain metastatic potential while preserving immune cell function. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2603440123